Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Kidney Infection Market, by Diagnosis
6.1 Introduction
6.2 Dipstick Urine Test
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Imaging Test
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Others
6.4.1 Market Estimates & Forecast, 2020-2027
7. Global Kidney Infection Market, by Treatment
7.1 Introduction
7.2 Medication
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Dialysis
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Kidney Transplant
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Others
7.5.1 Market Estimates & Forecast, 2020-2027
8. Global Kidney Infection Market, by End User
8.1 Introduction
8.2 Hospital & Clinics
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Nephrology Centers
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Research Institutes
8.4.1 Market Estimates & Forecast, 2020-2027
8.4 Others
8.4.1 Market Estimates & Forecast, 2020-2027
9. Global Kidney Infection Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K.
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
11 Company Profiles
11.1 AbbVie, Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.2 Allergan plc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.3 Amgen Inc.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.4 AstraZeneca
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 GlaxoSmithKline plc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Johnson & Johnson Services Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.8 Others
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Kidney Infection Industry
13 Appendix
LIST OF TABLES
Table 1 Kidney Infection Industry Synopsis, 2020-2027
Table 2 Global Kidney Infection Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Kidney Infection Market by Region, 2020-2027, (USD Million)
Table 4 Global Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 5 Global Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 6 Global Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 7 North America Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 8 North America Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 9 North America Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 10 U.S. Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 11 US Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 12 US Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 13 Canada Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 14 Canada Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 15 Canada Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 16 South America Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 17 South America Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 18 South America Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 19 Europe Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 20 Europe Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 21 Europe Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 22 Western Europe Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 23 Western Europe Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 24 Western Europe Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 25 Eastern Europe Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 26 Eastern Europe Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 27 Eastern Europe Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 28 Asia Pacific Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 29 Asia Pacific Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 30 Asia Pacific Kidney Infection Market by End Users, 2020-2027, (USD Million)
Table 31 Middle East & Africa Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
Table 32 Middle East & Africa Kidney Infection Market by Treatment, 2020-2027, (USD Million)
Table 33 Middle East & Africa Kidney Infection Market by End Users, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Kidney Infection Market
Figure 3 Segmentation Market Dynamics for Kidney Infection Market
Figure 4 Global Kidney Infection Market Share, by Diagnosis 2020
Figure 5 Global Kidney Infection Market Share, by Treatment 2020
Figure 6 Global Kidney Infection Market Share, by End Users, 2020
Figure 7 Global Kidney Infection Market Share, by Region, 2020
Figure 8 North America Kidney Infection Market Share, by Country, 2020
Figure 9 Europe Kidney Infection Market Share, by Country, 2020
Figure 10 Asia Pacific Kidney Infection Market Share, by Country, 2020
Figure 11 Middle East & Africa Kidney Infection Market Share, by Country, 2020
Figure 12 Global Kidney Infection Market: Company Share Analysis, 2020 (%)
Figure 13 Boston Scientific Corp: Key Financials
Figure 14 Boston Scientific Corp: Segmental Revenue
Figure 16 Boston Scientific Corp: Geographical Revenue
Figure 17 C.R. Bard Inc. Key Financials
Figure 18 C.R. Bard Inc. Segmental Revenue
Figure 19 C.R. Bard Inc. Geographical Revenue
Figure 20 Convergent Laser Technologies. Key Financials
Figure 21 Convergent Laser Technologies. Segmental Revenue
Figure 22 Convergent Laser Technologies: Geographical Revenue
Figure 23 Cook Medical Inc: Key Financials
Figure 24 Cook Medical Inc: Segmental Revenue
Figure 25 Cook Medical Inc: Geographical Revenue
Figure 26 DirexGroup: Key Financials
Figure 27 DirexGroup: Segmental Revenue
Figure 28 DirexGroup: Geographical Revenue
Figure 29 Dornier MedTech GmbH: Key Financials
Figure 30 Dornier MedTech GmbH: Segmental Revenue
Figure 31 Dornier MedTech GmbH: Geographical Revenue